Loading clinical trials...
Loading clinical trials...
The clinical trial assesses the effectiveness and safety of a genetically-determined personalized approach to prescribing bioactive substances in patients with elevated blood homocysteine levels. Hype...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
S.LAB (SOLOWAYS)
Collaborators
NCT07480265 · Hypertension (HTN), Hyperhomocysteinemia, and more
NCT00626223 · Mortality, Hyperhomocysteinemia, and more
NCT00473200 · Hyperhomocysteinemia
NCT01871740 · Hypertension, Hyperhomocysteinemia
NCT01391416 · Cardiovascular Disease, Hyperhomocysteinemia
Center of New Medical Technologies
Novosibirsk, Novosibisk Region
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions